The present invention is directed to formulations comprising 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives that modulate the activity of protein kinases (“PKs”). Methods of treating diseases related to abnormal PK activity utilizing the formulations
-
(2008/06/13)
More Articles about upstream products of 375824-74-1
Get Best Price for375824-74-1Carbamic acid,
[2-[(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2,3-dihydro-2-oxo-1
H-indol-1-yl]-2-oxoethyl]-, phenylmethyl ester